by lorenzgerber | Sep 23, 2026 | News
Biotech industry veteran with two decades of clinical development, manufacturing, and technical operations leadership to guide ImmunoScape’s “Seed and Boost” platform toward the clinic SINGAPORE & BOSTON—September 23, 2026 — ImmunoScape...
by lorenzgerber | Apr 25, 2026 | News
ImmunoScape presented new preclinical data at the AACR Annual Meeting 2026, highlighting the potential of its Seed and Boost™ platform in solid tumor immunotherapy. Key highlights from the study: Significant in vivo expansion of TCR-T cells using the Seed and Boost™...
by lorenzgerber | Mar 4, 2026 | News
The company also announced a strategic investment from Leonardo DiCaprio SINGAPORE and SAN DIEGO– ImmunoScape Pte. Ltd., an A*STAR spin-out backed by Amgen Ventures and EDBI that is developing next-generation TCR-based cancer immunotherapies, today announced the...
by lorenzgerber | Nov 13, 2025 | News
“Seed-and-Boost” Approach with Breakthrough Potential, Poised to Transform the Cancer Immunotherapy Landscape SINGAPORE — ImmunoScape Pte. Ltd., an A*STAR spin out backed by Amgen Ventures and EDBi that is developing next-generation TCR-based cancer...
